Abstract| Volume 43, ISSUE 12, P2387, December 2017

Familial hypocalciuric hypercalcaemia – An important differential to be considered before parathyroidectomy

      Introduction: Surgery is definitive treatment for primary hyperparathyroidism (PHPT). However it is vital to exclude familial hypocalciuric hypercalcaemia (FHH) in hypercalcaemic patients as a differential prior to surgery. FHH is rare and follows a benign course; surgery is unnecessary and often fails to correct hypercalcaemia. This study presents a series of patients with suspected FHH who had gene testing in a single tertiary centre.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to European Journal of Surgical Oncology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect